Based in Cambridge, MA, STRM.BIO (pronounced “storm bio”) is a pre-clinical, VC-backed biotechnology company that aims to fulfill the promise of gene therapy by leveraging extracellular vesicles (EVs) to deliver treatment directly to the patient (in vivo). At STRM.BIO, we believe that our work has the potential to democratize genetic medicines and bring hope for patients fighting rare diseases worldwide. We are currently recruiting team members who can help us make our vision a life-saving reality. Learn more at strm.bio/careers.
